BK Polyomavirus Status Prior to Allogenic Hematopoietic Stem Cell Transplant Is Predictive of BK Hemorrhagic Cystitis Related Transplant Outcomes in Pediatric and Young Adult Patients

Xiaopei Lily Zeng(Northwestern University), Sonali Chaudhury(Northwestern University), Hannah Lust(Northwestern University), Veronika Polishchuk(Albert Einstein College of Medicine), Jennifer Schneiderman(Northwestern University), William J. Muller(Lurie Children's Hospital), Kevin O. McNerney(Children's Hospital of Philadelphia)
Transplantation and Cellular Therapy
February 1, 2025
10.1016/j.jtct.2025.01.818
Cited by 0

Related Papers

Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)
|Clinical Infectious Diseases|2020|1.1k
Allogeneic Human Mesenchymal Stem Cell Therapy (Remestemcel-L, Prochymal) as a Rescue Agent for Severe Refractory Acute Graft-versus-Host Disease in Pediatric Patients
|Transplantation and Cellular Therapy|2013|248
Deep immune profiling of MIS-C demonstrates marked but transient immune activation compared with adult and pediatric COVID-19
|Science Immunology|2021|206
Unrelated Donor Cord Blood Transplantation for Children with Severe Sickle Cell Disease: Results of One Cohort from the Phase II Study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)
|Transplantation and Cellular Therapy|2012|201
A Phase 3, Single-Arm, Prospective Study of Remestemcel-L, Ex Vivo Culture-Expanded Adult Human Mesenchymal Stromal Cells for the Treatment of Pediatric Patients Who Failed to Respond to Steroid Treatment for Acute Graft-versus-Host Disease
|Transplantation and Cellular Therapy|2020|201